GSK‐3 in Neurodegenerative Diseases

Lei, Peng, Ayton, Scott, Bush, Ashley I., Adlard, Paul A.·2011·International Journal of Alzheimer’s Disease
DOI 10.4061/2011/189246

Cited by (181)

Items 101–181 of 181

  1. Involvement of ‘stress–response’ kinase pathways in Alzheimer's disease progression
    Georges Mairet‐Coello, Franck Polleux · 2014 · Current Opinion in Neurobiology
  2. Glycogen synthase kinase-3β regulates fractalkine production by altering its trafficking from Golgi to plasma membrane: implications for Alzheimer’s disease
    Almudena Fuster-Matanzo, Jerónimo Jurado‐Arjona, Stefano Benvegnù, Esther García, Patricia Martín-Maestro, Raquel Gómez‐Sintes, Félix Hernández, Jesús Ávila · 2016 · Cellular and Molecular Life Sciences
  3. Radiofluorination of oxazole-carboxamides for preclinical PET neuroimaging of GSK-3
    Cassis Varlow, Andrew V. Mossine, Vadim Bernard‐Gauthier, Peter J. H. Scott, Neil Vasdev · 2021 · Journal of Fluorine Chemistry
  4. Computational Drug Repurposing for Neurodegenerative Diseases
    Kyriaki Savva, Margarita Zachariou, Anastasis Oulas, George Minadakis, Kleitos Sokratous, Nikolas Dietis, George M. Spyrou · 2019 · Elsevier eBooks
  5. Thiadiazolidinone (TDZD) Analogs Inhibit Aggregation-Mediated Pathology in Diverse Neurodegeneration Models, and Extend C. elegans Life- and Healthspan
    Samuel Kakraba, Srinivas Ayyadevara, Nirjal Mainali, Meenakshisundaram Balasubramaniam, Suresh Bowroju, Narsimha Reddy Penthala, Ramani Atluri, Steven W. Barger, Sue T. Griffin, Peter Anthony Crooks et al. · 2023 · Pharmaceuticals
  6. Fluoxetine Inhibits Natural Decay of Long-Term Memory via Akt/GSK-3β Signaling
    Jee Hyun Yi, JiaBao Zhang, Sang Yoon Ko, Huiyoung Kwon, Se Jin Jeon, Se Jin Park, Ji-Wook Jung, Byung C. Kim, Young Choon Lee, Dong Hyun Kim et al. · 2018 · Molecular Neurobiology
  7. Tau protein phosphorylation at Thr175 initiates fibril formation via accessibility of the N‐terminal phosphatase‐activating domain
    Matthew A Hintermayer, Kathryn Volkening, Alexander Joseph Moszczynski, Neil S. Donison, Michael Joseph Strong · 2019 · Journal of Neurochemistry
  8. A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer’s Disease
    Rubayat Islam Khan, Saif Shahriar Rahman Nirzhor, Barnaly Rashid · 2018 · Brain Sciences
  9. Upregulation of the PI3K/AKT and Nrf2 Pathways by the DPP-4 Inhibitor Sitagliptin Renders Neuroprotection in Chemically Induced Parkinson’s Disease Mouse Models
    Ritu Soni, Vaishali Pankaj, Sudeep Roy, Amit Khairnar, Jigna Shah · 2025 · ACS Chemical Neuroscience
  10. Neuropathological Mechanisms of β-N-Methylamino-L-Alanine (BMAA) with a Focus on Iron Overload and Ferroptosis
    Hamed Kazemi Shariat Panahi, Mona Dehhaghi, Benjamin Heng, Darius J.R. Lane, Ashley Ian Bush, Gilles J. Guillemin, Vanessa X. Tan · 2022 · Neurotoxicity Research
  11. In Vivo Imaging and Kinetic Modeling of Novel Glycogen Synthase Kinase-3 Radiotracers [11C]OCM-44 and [18F]OCM-50 in Non-Human Primates
    Kelly A. Smart, Ming‐Qiang Zheng, Daniel Holden, Zachary Felchner, Li Zhang, Yanjiang Han, Jim R. Ropchan, Richard E. Carson, Neil Vasdev, Yiyun Henry Huang · 2023 · Pharmaceuticals
  12. Tau Acts in Concert With Kinase/Phosphatase Underlying Synaptic Dysfunction
    Xing Fan, Liye Xia, Zheng Zhou, Yanyan Qiu, Chenhao Zhao, Xiaomin Yin, Wei Qian · 2022 · Frontiers in Aging Neuroscience
  13. Diabetes in Pregnancy Adversely Affects the Expression of Glycogen Synthase Kinase-3β in the Hippocampus of Rat Neonates
    Javad Hami, Razieh Karimi, Hossein Haghir, Mehran Gholamin, Ariane Sadr‐Nabavi · 2015 · Journal of Molecular Neuroscience
  14. Neuroinflammation to neurodegeneration: Boulevard of broken nerves
    Ali Attiq, Sheryar Afzal, Hemavalli Raman, Waqas Ahmad · 2025 · International Immunopharmacology
  15. Hyperglycemia-Driven Insulin Signaling Defects Promote Parkinson’s Disease-like Pathology in Mice
    Ritu Soni, Kirti Mathur, Hritik Rathod, Amit Khairnar, Jigna Shah · 2024 · ACS Pharmacology & Translational Science
  16. Decoding the Role of Neurotrophins in Glycogen Synthase Kinase 3-Beta Regulation in Alzheimer’s Disease
    Shubham Nilkanth Rahmatkar, Damanpreet Singh · 2025 · Molecular Neurobiology
  17. Tideglusib Ameliorates Ischemia/Reperfusion Damage by Inhibiting GSK-3β and Apoptosis in Rat Model of Ischemic Stroke
    Balu Joshi, Devendra Singh, Himika Wasan, Uma Sharma, K.H. Reeta · 2022 · Journal of Stroke and Cerebrovascular Diseases
  18. The Possible Role of Naringenin in the Prevention of Alcohol-Induced Neurochemical and Neurobehavioral Deficits
    Nema Ali Soliman, Muhammad Tarek Abdel Ghafar, Norhan Ahmed AbuoHashish, Marwa A. Ibrahim, Asmaa Eid, Rehab M. El‐Gohary, Rehab E. Abo El Gheit, Amira Mostafa Elshamy · 2022 · Neurochemical Research
  19. Technical considerations in detection of HERV-K in amyotrophic lateral sclerosis: selection of controls and the perils of qPCR
    Marta Garcia Montojo, Wenxue Li, Avindra Nath · 2019 · Acta Neuropathologica Communications
  20. Synthesis and preliminary evaluation of novel PET probes for GSK-3 imaging
    Surendra Reddy Gundam, Aditya Bansal, Manasa Kethamreddy, Sujala Ghatamaneni, Val J. Lowe, Melissa Erin Murray, Mukesh K. Pandey · 2024 · Scientific Reports
  21. Neurodegenerative phosphoprotein signaling landscape in models of SCA3
    Anna Sergeevna Sowa, Taissia G. Popova, Tina Harmuth, Jonasz Jeremiasz Weber, Priscila Pereira Sena, Jana Schmidt, Jeannette Hübener‐Schmid, Thorsten Schmidt · 2021 · Molecular Brain
  22. Oligomeric and Fibrillar Species of Aβ42 Diversely Affect Human Neural Stem Cells
    Adela Bernabeu-Zornoza, Raquel Coronel, Charlotte Palmer, Victoria López-Alonso, Isabel Liste · 2021 · International Journal of Molecular Sciences
  23. Caloric restriction mimetic 2-deoxyglucose maintains cytoarchitecture and reduces tau phosphorylation in primary culture of mouse hippocampal pyramidal neurons
    M. S. Bele, K. A. Gajare, A. A. Deshmukh · 2015 · In Vitro Cellular & Developmental Biology - Animal
  24. The Role of p53 in Alzheimer’s Disease: Impact on Tau Pathology
    Maja Jazvinšćak Jembrek, Katy Newberg, Goran Šimić · 2018 · Springer eBooks
  25. The A -Induced NFAT Apoptotic Pathway Is Also Activated by GSK-3 Inhibition: Implications for Alzheimer Therapeutics
    Scott Ayton, Peng Lei · 2012 · Journal of Neuroscience
  26. Glycogen synthase kinase-3: the master switch driving neurodegeneration in Alzheimer’s disease and Parkinson’s disease
    Yifang Liu, Jingru Zhang, Luhong Tang, Jiaoyan Yang, Liying Hao, Fan Lou, Jingyang Su · 2025 · Archives of Toxicology
  27. Precision Enzyme: Targeted Drug Discovery in Neurodegenerative Disorders
    Sampriti Paul, Prashant Kumar Tiwari, Sonal Dubey · 2025 · Protein and Peptide Letters
  28. Effect of JGK-263 as a new glycogen synthase kinase-3β inhibitor on extrinsic apoptosis pathway in motor neuronal cells
    Gye Sun Jeon, Jee‐Eun Kim, Suk-Won Ahn, Kyung Seok Park, Yoon‐Ho Hong, In-Hae Ye, Ji-Seon Park, Seung Hyun Kim, Kwang Woo Lee, Sung‐Min Kim et al. · 2013 · Biochemical and Biophysical Research Communications
  29. 18 F‐Radiopharmaceutical Diversification Enabled by Deaminative Cross‐Electrophile Couplings
    Isabella F. Ogilvy, Joseph Ford, Sebastiano Ortalli, Evelien Renders, Thomas R. Hayes, Shuanglong Liu, Inne Mortiers, Anastasia Nikolopoulou, Alexandre M. Sorlin, Andrés A. Trabanco et al. · 2025 · Angewandte Chemie International Edition
  30. Reimagining GSK-3β Therapeutics in Alzheimer’s Disease: From Inhibition to Activity Normalization and Targeted Degradation
    Emad Manni, Hayder M. Al‐kuraishy, Rabab Eisawy, Ahmed M Abdelaziz, Gaber El‐Saber Batiha · 2026 · Journal of Molecular Neuroscience
  31. Analysing the role of Saraswatarishta in the treatment of neurological disorders based on network pharmacology
    Vrinda Jethalia, Sanjana Varada Hasyagar, Kasturi Bhamidipati, Jhinuk Chatterjee · 2021 · Neuroscience Research Notes
  32. The Effete of Lithium Chloride on the Granular Cell Density in Cerebellar Folia V and VI in a Trimethyltin Intoxication Model
    Solmaz Shams-Alam, Mohammad Amin Edalatmanesh · 2015 · The Neuroscience Journal of Shefaye Khatam
  33. Long-term depression-related tau phosphorylation is enhanced by methylene blue in healthy rat hippocampus
    Cem Süer, N. Yıldız Demircan, Özlem Barutçu, Burak Tan, Nurcan Dursun · 2021 · Pharmacological Reports
  34. Pathophysiological mechanism and natural preventive and therapeutic strategies of Alzheimer's disease
    Abdelkader Basli, Jihane Bounaas · 2022 · Nutrition and Health
  35. Rational Design of Dual Inhibitors for Alzheimer's Disease: Insights from Computational Screening of BACE1 and GSK-3β
    Magham Sai Varshini, Ramakkamma Aishwarya Reddy, Praveen Thaggikuppe Krishnamurthy, Divakar Selvaraj · 2023 · Current Computer - Aided Drug Design
  36. GSK-3: An “Ace” Among Kinases
    Theodore Lemuel Mathuram · 2024 · Cancer Biotherapy and Radiopharmaceuticals
  37. Evaluation of Nrf2/Keap1 Pathway in Patients with Migraine
    Fatih Koçtürk, Firdevs Emekli, Kadir Eği, Seyithan Tayşi · 2025 · Medicina
  38. Insulin and TLR4 Inhibitor Improve Motor Impairments in a Rat Model of Parkinson’s Disease
    Fatemeh Hemmati, Neda Valian, Abolhassan Ahmadiani, Zahurin Mohamed, Azman Ali Raymond, Norlinah Mohamed Ibrahim, Seyed Farshad Hosseini Shirazi · 2024 · Iranian journal of pharmaceutical research
  39. Modulating Role of TTR in Aβ Toxicity, from Health to Disease
    Isabel Cardoso, Luís Miguel Santos, Mobina Alemi · 2016 · InTech eBooks
  40. Decoding the Role of Nuclear Sirtuins in Parkinson’s Pathogenesis
    Dishank Patel, Ritu Soni, Jigna Shah · 2024 · ACS Chemical Neuroscience
  41. Investigation of the Mechanisms of Neuroprotection Mediated by Lobelia Species via Computational Network Pharmacology and Molecular Modeling
    Qinfang Zheng, Liang-zi Fang, Xiaolong Huang, Ye Wang, Shuihan Zhang · 2020 · Research Square
  42. GLP1 secretagogue cinnamaldehyde upregulates GLP1/PI3K/AKT and Nrf2 pathways to exert neuroprotection in a rotenone induced mouse model of Parkinson's disease
    Kirti Mathur, Ritu Soni, Ruchi Yadav, Bhumika Patel, Jigna Shah · 2025 · International Journal of Biological Macromolecules
  43. Anticancer Properties of Antipsychotic Drugs
    Milica Borovčanin, Bojan Stojanović, Milica Dimitrijevic Stojanovic, Bojana Stojanović, Aleksandar Lazovic, Marina M. Mitrović · 2024 · Interdisciplinary cancer research
  44. Comparison of [18F]F‐CNBI and [18F]F‐CNPIFE as Positron Emission Tomography Probes for Noninvasive Imaging of Glycogen Synthase Kinase‐3 in Normal Mice
    Heather M. Stein, Surendra R. Gundam, Aditya Bansal, Nicholas R. Nelson, Geoffry L. Curran, Timothy R. DeGrado, Mark A. Frye, John D. Port, Val J. Lowe, Melissa Erin Murray et al. · 2022 · European Journal of Organic Chemistry
  45. The Lithium Chloride Effect on Anxiety, Exploratory Activity, and Brain Derived Neurotrophic Factor Levels of the Hippocampus in a Rat Model of TMT Intoxication
    Marzieh Moghadas, Mohammad Amin Edalatmanesh · 2015 · The Neuroscience Journal of Shefaye Khatam
  46. Trimethyltin can induce cell death in the entorhinal cortex of rat brain: a histological architecture and neuronal density evaluation of the neuroprotective role of lithium chloride
    Mahin Homayoon, Mohammad Amin Edalatmanesh, Marzieh Moghadas · 2014 · Comparative Clinical Pathology
  47. Proposed Prophylactic use of Lithium to improve Cognitive Decline and Mental Health in Disorders such as Alzheimerʼs Disease and Depression
    Jessica L Foster, Vincent S. Gallicchio · 2018 · Madridge Journal of Clinical Research
  48. Role of GSK-3 Inhibition in Alzheimer’s Disease Therapy
    Hala Algazzawi, Jakleen Ziyad Abujamai, Asim Muhammed Alshanberi, Rukhsana Satar, Shakeel Ahmed Ansari · 2025 · Current Alzheimer Research
  49. Unraveling the Effects of GSK-3β Isoform Modulation against Limbic Seizures and in the 6 Hz Electrical Kindling Model for Epileptogenesis
    Najat Aourz, Fred VAN LEUVEN, Wissal Allaoui, Ann Van Eeckhaut, Dimitri De Bundel, Ilse Julia Smolders · 2022 · ACS Chemical Neuroscience
  50. Targeting Impaired Nutrient Sensing via the Glycogen Synthase Kinase-3 Pathway With Therapeutic Compounds to Prevent or Treat Dementia: A Systematic Review
    Adrian Matysek, Sumudu Perera Kimmantudawage, Lei Feng, Andrea Britta Maier · 2022 · Frontiers in Aging
  51. Sex differences in neuronal oscillatory activity and memory in the methylazoxymethanol acetate model of schizophrenia
    Abdalla M. Albeely, Olivia O. F. Williams, Colin R. Blight, Rachel-Karson Thériault, Melissa L. Perreault · 2024 · Schizophrenia Research
  52. Neurodegeneration: A Leg Up on TDP-43
    Matthew D. Figley, Aaron D. Gitler · 2015 · Current Biology
  53. TDZD-8 pre-treatment in transient middle cerebral artery occlusion
    Bernardo Oliveira Ratilal, João Pedro Rocha, Adelaide Maria Afonso Fernandes, Mariana Moreira Coutinho Arroja, Andreia Pereira Barateiro, Dora Maria Tuna Oliveira Brites, Rui M. A. Pinto, Bruno Miguel Nogueira Sepodes, Hélder Mota‐Filipe · 2014 · Biomedicine & Aging Pathology
  54. Anti-parkinsonian efficacy of target-specific GSK3β inhibitors demonstrated in Caenorhabditis elegans
    Hanumanthappa Pradeep, Shivaiah Shashikumar, P.S. Rajini, Golgodu Krishnamurthy Rajanikant · 2014 · Medicinal Chemistry Research
  55. Extrinsic Apoptosis Pathway Altered by Glycogen Synthase Kinase-3β Inhibitor Influences the Net Drug Effect on NSC-34 Motor Neuron-Like Cell Survival
    Jee‐Eun Kim, Jung Hyun Lim, Gye Sun Jeon, Je-Young Shin, Suk-Won Ahn, Seung Hyun Kim, Kwang Woo Lee, Yoon‐Ho Hong, Jung‐Joon Sung · 2017 · BioMed Research International
  56. Contrasting Effects of Inhibitors Li + and Be 2+ on Catalytic Cycle of Glycogen Synthase Kinase-3β
    David J. Reilley, Zaher Arraf, Anastassia N. Alexandrova · 2021 · The Journal of Physical Chemistry B
  57. Reshaping cytoskeleton: different acts of modulatory compounds
    Pelin Zobaroğlu-Özer, Gamze Bora · 2020 · Istanbul Journal of Pharmacy
  58. Maternal Bisphenol A Exposure Induces Hippocampal‐Dependent Learning and Memory Deficits Through the PI3K/Akt/mTOR Pathway in Male Offspring Rats
    Jiajia Ren, Wenjie Bai, Yi Guo, Qiling Liu, Yuxin Wang, Chong Wang · 2025 · Journal of Biochemical and Molecular Toxicology
  59. Glycogen synthase kinase-3 activation and dysregulation of amyloid transport receptors expression and shedding in HIV-induced Alzheimer’s disease-like pathology: modulatory effects of CCR5 antagonists
    Biju Bhargavan, Narendran Annadurai, Georgette D. Kanmogne · 2025 · Acta Neuropathologica Communications
  60. Phosphatidylinositol-3-kinase/Protein Kinase B (PI3K/AKT) and Nucleotide-Binding Oligomerization Domain-like Receptor Family Pyrin Domain Containing 3 (NLRP3) Inflammasome Modulation Underlies the Neuroprotective Effects of Vildagliptin in a Rotenone-Induced Mouse Model of Parkinson’s Disease
    Dishank Patel, Ritu Soni, Inderjeet Bhogal, Sudeep Roy, Jigna Shah · 2026 · ACS Pharmacology & Translational Science
  61. Navigating the Complexity: A Comprehensive Review of GSK‐3 Inhibition in Regenerative Medicine
    Davide Schiroli, Alessia Merra, Chiara Marraccini, Lucia Merolle, Graziella Pellegrini, Eleonora Maurizi · 2026 · Medicinal Research Reviews
  62. Degenerative Brain Diseases and White Matter Injury
    George Bartzokis, Po H. Lu · 2013 · Springer eBooks
  63. HDAC Inhibitors as Novel Therapeutic Option Against Therapeutically Challenging Neurological Disorders
    Shabir Ahmad Ganai · 2019 · Springer eBooks
  64. ELEMENTARY PATHOPHYSIOLOGY, TREATMENT, RISK FACTOR OF ALZHEIMER’S DISEASE
    2022 · International Research Journal of Modernization in Engineering Technology and Science
  65. Parkinson's Disease
    Vaibhav Walia, Ashish Gakkhar, Munish Garg · 2018 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  66. PET and SPECT Studies of Ageing and Cardiovascular Risk Factors for Alzheimer’s Disease
    Geraldo F. Busatto, Jaqueline H. Tamashiro-Duran, Tania Correa de Toledo, Luiz Kobuti Ferreira, Fábio Duran, Carlos Alberto Buchpiguel · 2014 · Springer eBooks
  67. Use it and boost it: Cognitive and physical activities modulate cognition via BDNF-TrkB signaling
    Claire J. Scavuzzo · 2014 · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
  68. The Role of the Dopamine D5 Receptor and D1-D2 Receptor Heterooligomer Signalling in Rodent Prefrontal Cortex and Cognition
    David Pok Yik Yeung · 2015 · TSpace (University of Toronto)
  69. Redox Signalling in Dopaminergic Cell Death and Survival
    Ajit Ray, Aditi Verma, Vijayalakshmi Ravindranath · 2017 · Royal Society of Chemistry eBooks
  70. HEALTHY AGING
    Constantin Munteanu · 2013 · Romanian Association of Balneology eBooks
  71. Unprecedented prospects as forthcoming drug targets: New boulevard in the cure and treatment of neurodegenerative disorders
    Dipanjan Karati, Swarupananda Mukherjee, Nandita Batabyal · 2024 · Elsevier eBooks
  72. 18 F‐Radiopharmaceutical Diversification Enabled by Deaminative Cross‐Electrophile Couplings
    Isabella F. Ogilvy, Joseph Ford, Sebastiano Ortalli, Evelien Renders, Thomas R. Hayes, Shuanglong Liu, Inne Mortiers, Anastasia Nikolopoulou, Alexandre M. Sorlin, Andrés A. Trabanco et al. · 2025 · Angewandte Chemie
  73. Additional file 1 of Neurodegenerative phosphoprotein signaling landscape in models of SCA3
    Anna Sergeevna Sowa, Taissia G. Popova, Tina Harmuth, Jonasz Jeremiasz Weber, Pereira Sena, Priscila, Schmidt, Jana, Jeannette Hübener‐Schmid, Thorsten Schmidt · 2021 · Figshare
  74. Nutrigenomic influence of a curcumin-supplemented high glycemic diet on hippocampal microvasculature in male C57BL/6J mice
    Emilio Balbuena, Jennifer M. Rutkowsky, Saivageethi Nuthikattu, Amparo C. Villablanca, Dragan Milenković · 2026 · Frontiers in Nutrition
  75. Identification and Characterization of New Therapeutic Targets in Acute Myeloid Leukemia
    Lina Benajiba · 2018 · theses.fr (ABES)
  76. Neuroprotection of engineered Clostridium butyricum-pMTL007-GLP-1 in A53T α-synuclein (α-syn) mouse model via PI3K/AKT/GSK-3β
    Xin Fang, Yue Wang, Zhenli Long, Bin Liao, Bo Wang, Daojun Hong, Jie Luo, Tingtao Chen · 2026 · Journal of Zhejiang University SCIENCE B
  77. Integrative bioinformatics and docking-based in silico toxicity assessment of plastic additives: Insights into neurotoxic, reproductive, and carcinogenic risks and associated molecular pathways
    Vedika Jain, Sharda Bharti · 2026 · Food and Chemical Toxicology
  78. BindingDB Entry 50018638: Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).
    BindingDB · 2024 · UC San Diego
  79. BindingDB Entry 50010629: Optimization of Indazole-Based GSK-3 Inhibitors with Mitigated hERG Issue and
    BindingDB · 2021 · UC San Diego
  80. BindingDB Entry 50017428: The Repertoire of Small-Molecule PET Probes for Neuroinflammation Imaging: Challenges and Opportunities beyond TSPO.
    BindingDB · 2023 · UC San Diego
  81. BindingDB Entry 50046824: Evaluation of Improved Glycogen Synthase Kinase-3a Inhibitors in Models of Acute Myeloid Leukemia.
    BindingDB · 2016 · UC San Diego